Ding et al. [45] found that apatinib could suppress tumor growth, migration, and epithelial-mesenchymal transition of OC cells in vivo and in vitro by inhibiting the JAK/STAT3, PI3K/AKT, and Notch signal pathways. The gene discussed is AKT1; the disease is neoplasm.